Monahan Joseph
Insider CIK 1861790 · ACRS Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 50,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 10,925 | — | $0 | 10,925 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-03-01 | 2025-03-04 | 27,258 | $1.99 | $54.2K | 265,662 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-03-01 | 2025-03-04 | 10,925 | — | $0 | 292,920 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-03-01 | 2025-03-04 | 50,000 | — | $0 | 281,995 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 83,900 | — | $0 | 83,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 293,500 | — | $0 | 293,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-02-01 | 2025-02-04 | 7,500 | — | $0 | 15,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-02-01 | 2025-02-04 | 14,750 | — | $0 | 44,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-02-01 | 2025-02-04 | 14,750 | — | $0 | 243,312 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-02-01 | 2025-02-04 | 11,317 | $2.48 | $28.1K | 231,995 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-02-01 | 2025-02-04 | 7,500 | — | $0 | 228,562 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 52,667 | — | $0 | 52,667 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-01-02 | 2025-01-03 | 17,380 | — | $0 | 35,287 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-01-02 | 2025-01-03 | 17,380 | — | $0 | 229,976 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-01-02 | 2025-01-03 | 8,914 | — | $0 | 221,062 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 73,750 | — | $0 | 73,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 73,750 | — | $0 | 245,533 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-12-31 | 2025-01-03 | 32,937 | — | $0 | 212,596 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | G Gift | 2024-12-10 | 2024-12-12 | 15,000 | — | $0 | 171,783 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-03-02 | 2024-03-05 | 12,500 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-03-02 | 2024-03-05 | 3,531 | $1.24 | $4.4K | 186,783 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-03-02 | 2024-03-05 | 12,500 | — | $0 | 190,314 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 10,925 | — | $0 | 21,850 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-03-01 | 2024-03-05 | 50,000 | — | $0 | 184,641 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 14,569 | $1.24 | $18.1K | 170,072 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-03-01 | 2024-03-05 | 10,925 | — | $0 | 180,997 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 3,183 | $1.24 | $3.9K | 177,814 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 206,500 | — | $0 | 206,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 59,000 | — | $0 | 59,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 147,500 | — | $0 | 147,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-02-01 | 2024-02-05 | 7,500 | — | $0 | 22,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-02-01 | 2024-02-05 | 7,500 | — | $0 | 137,224 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-02-01 | 2024-02-05 | 2,583 | $1.20 | $3.1K | 134,641 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-10-23 | 2023-10-25 | 6,000 | $5.08 | $30.5K | 129,724 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-08-21 | 2023-08-22 | 6,000 | $7.32 | $43.9K | 135,724 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-06-20 | 2023-06-22 | 6,000 | $10.28 | $61.7K | 141,724 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-03-03 | 2023-03-03 | 16,037 | $12.63 | $202.5K | 147,724 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-02 | 2023-03-03 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 14,800 | $12.37 | $183.1K | 151,261 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-02 | 2023-03-03 | 12,500 | — | $0 | 163,761 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 10,925 | — | $0 | 32,775 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 50,000 | — | $0 | 100,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 13,750 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 10,925 | — | $0 | 166,061 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 13,750 | — | $0 | 105,136 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 50,000 | — | $0 | 155,136 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-02-15 | 2023-02-17 | 5,000 | $13.06 | $65.3K | 91,386 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 105,000 | — | $0 | 105,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-12-15 | 2022-12-16 | 5,000 | $15.88 | $79.4K | 96,386 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-10-17 | 2022-10-19 | 5,000 | $15.98 | $79.9K | 101,386 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-04-18 | 2022-04-20 | 30,000 | $16.28 | $488.4K | 106,386 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-03-10 | 2022-03-14 | 27,165 | $15.71 | $426.8K | 136,386 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-02 | 2022-03-03 | 12,500 | — | $0 | 25,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-02 | 2022-03-03 | 12,500 | — | $0 | 163,551 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 50,000 | — | $0 | 150,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 43,700 | — | $0 | 43,700 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 153,100 | — | $0 | 153,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 50,000 | — | $0 | 151,051 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 13,750 | — | $0 | 101,051 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-02-09 | 2022-02-11 | 383 | $12.68 | $4.9K | 87,301 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 1,050 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 1,050 | — | $0 | 87,684 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-09-01 | 2021-09-02 | 2,333 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-09-01 | 2021-09-02 | 2,333 | — | $0 | 87,675 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-09-01 | 2021-09-02 | 1,041 | $17.22 | $17.9K | 86,634 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 18,240 | $21.50 | $392.2K | 88,892 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 3,550 | $22.31 | $79.2K | 85,342 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 50,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 50,000 | — | $0 | 107,132 | SEC↗ |